These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 24652192)
1. STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma. Lin GS; Yang LJ; Wang XF; Chen YP; Tang WL; Chen L; Lin ZX Med Oncol; 2014 Apr; 31(4):924. PubMed ID: 24652192 [TBL] [Abstract][Full Text] [Related]
2. STAT3 serine 727 phosphorylation influences clinical outcome in glioblastoma. Lin GS; Chen YP; Lin ZX; Wang XF; Zheng ZQ; Chen L Int J Clin Exp Pathol; 2014; 7(6):3141-9. PubMed ID: 25031733 [TBL] [Abstract][Full Text] [Related]
3. Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression. Mu L; Wang Y; Wang Y; Zhang H; Shang D; Tan F; Li Y; Chen X World Neurosurg; 2017 Jan; 97():279-283. PubMed ID: 27744078 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of STAT3 gene expression in patients with glioblastoma tumors: a study from Western India. Trivedi T; Panchal K; Bhalala N; Trivedi P J Egypt Natl Canc Inst; 2022 Jul; 34(1):30. PubMed ID: 35844028 [TBL] [Abstract][Full Text] [Related]
5. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients. Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780 [TBL] [Abstract][Full Text] [Related]
6. Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma. Januel E; Ursu R; Alkhafaji A; Marantidou A; Doridam J; Belin C; Levy-Piedbois C; Carpentier AF Eur J Neurol; 2015 Sep; 22(9):1304-9. PubMed ID: 26053493 [TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme. Cetin B; Gonul II; Gumusay O; Bilgetekin I; Algin E; Ozet A; Uner A Neuropathology; 2018 Oct; 38(5):457-462. PubMed ID: 29952031 [TBL] [Abstract][Full Text] [Related]
8. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389 [TBL] [Abstract][Full Text] [Related]
9. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma. Shwetha SD; Shastry AH; Arivazhagan A; Santosh V Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways. Wang Y; Chen L; Bao Z; Li S; You G; Yan W; Shi Z; Liu Y; Yang P; Zhang W; Han L; Kang C; Jiang T Oncol Rep; 2011 Nov; 26(5):1173-80. PubMed ID: 21887474 [TBL] [Abstract][Full Text] [Related]
11. Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma. Rudra S; Hui C; Rao YJ; Samson P; Lin AJ; Chang X; Tsien C; Fergus S; Mullen D; Yang D; Thotala D; Hallahan D; Campian JL; Huang J Int J Radiat Oncol Biol Phys; 2018 May; 101(1):217-225. PubMed ID: 29502931 [TBL] [Abstract][Full Text] [Related]
12. [Clinical prognostic factors of adult supratentorial glioblastoma]. Jiang HH; Ren XH; Cui Y; Li MX; Yang KY; Lei YF; Lin S Zhonghua Wai Ke Za Zhi; 2019 May; 57(5):377-382. PubMed ID: 31091594 [No Abstract] [Full Text] [Related]
13. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma. Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833 [TBL] [Abstract][Full Text] [Related]
15. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. Gilbert MR; Wang M; Aldape KD; Stupp R; Hegi ME; Jaeckle KA; Armstrong TS; Wefel JS; Won M; Blumenthal DT; Mahajan A; Schultz CJ; Erridge S; Baumert B; Hopkins KI; Tzuk-Shina T; Brown PD; Chakravarti A; Curran WJ; Mehta MP J Clin Oncol; 2013 Nov; 31(32):4085-91. PubMed ID: 24101040 [TBL] [Abstract][Full Text] [Related]
16. Vitronectin significantly influences prognosis in osteosarcoma. Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861 [TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide. Saito T; Sugiyama K; Takeshima Y; Amatya VJ; Yamasaki F; Takayasu T; Nosaka R; Muragaki Y; Kawamata T; Kurisu K J Neurosurg; 2018 Mar; 128(3):679-684. PubMed ID: 28430038 [TBL] [Abstract][Full Text] [Related]
18. Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice. Roux A; Peeters S; Zanello M; Bou Nassif R; Abi Lahoud G; Dezamis E; Parraga E; Lechapt-Zalcmann E; Dhermain F; Dumont S; Louvel G; Chretien F; Sauvageon X; Devaux B; Oppenheim C; Pallud J J Neurooncol; 2017 Oct; 135(1):83-92. PubMed ID: 28669011 [TBL] [Abstract][Full Text] [Related]
19. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Tong L; Li J; Li Q; Wang X; Medikonda R; Zhao T; Li T; Ma H; Yi L; Liu P; Xie Y; Choi J; Yu S; Lin Y; Dong J; Huang Q; Jin X; Lim M; Yang X Theranostics; 2020; 10(13):5943-5956. PubMed ID: 32483429 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of concomitant radiotherapy in newly diagnosed glioblastoma multiforme: a multivariate analysis of 116 patients. Okumus NO; Gursel B; Meydan D; Ozdemir O; Odabas E; Gonullu G Ann Saudi Med; 2012; 32(3):250-5. PubMed ID: 22588435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]